Salesforce Roundtable
Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs
Fire and NICE
UK agency takes the heat for slow evaluations and failing to consider societal benefits of new drugs
Open Season on FDA
Congress is firing plenty of ammunition at pharma companies-and the regulators
Education Trumps Regulation
New research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard
Study Rescue
Pharma companies must quit wasting money and get strategic when mapping out their clinical study strategies
Earning the Public Trust—and Keeping It
The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?
In Praise of Independence: Q&A with Roche's Dan Zabrowski
Roche has always gone its own way with biologics, deals, and new medicines. Now that the rest of industry has caught on, how can Roche stay ahead of its time?
The New Name of the Game: Adherence
Why Big Pharma can no longer afford to treat patient adherence programs as an afterthought
Watch that Reputation
Defending your brand through search optimization
e-Pedigree to the Next Degree
Electronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking
